Metraipolis › archive › dc_2305420cffce
Multidimensional impact of fixed-dose subcutaneous trastuzumab-pertuzumab on oncology workflow and patient time burden in a real-world study — Europe PMC PMID:41343011
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41343011
- DOI
- 10.1007/s12282-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T22:09:57.896Z
- SHA-256 of the archived text
f3f1b15f26d4366a7edfd2c8c535c2d8ce636db84992ab3a5d202ef34d14e396- Stable URL of this page
https://metraipolis.com/documento/dc_2305420cffce
How to cite
Multidimensional impact of fixed-dose subcutaneous trastuzumab-pertuzumab on oncology workflow and patient time burden in a real-world study — Europe PMC PMID:41343011 — Europe PMC (en), https://europepmc.org/article/MED/41343011 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2305420cffce (Metraipolis archive dc_2305420cffce, sha256 f3f1b15f26d4366a7edfd2c8c535c2d8ce636db84992ab3a5d202ef34d14e396)
BibTeX
@misc{dc2305420cffce,
title = {Multidimensional impact of fixed-dose subcutaneous trastuzumab-pertuzumab on oncology workflow and patient time burden in a real-world study — Europe PMC PMID:41343011},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41343011},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2305420cffce; sha256 f3f1b15f26d4366a7edfd2c8c535c2d8ce636db84992ab3a5d202ef34d14e396},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41343011. Agents can read the archived copy with the MCP tool read_document.